125 related articles for article (PubMed ID: 25513716)
1. An immunogenetic study of bullous pemphigoid with mucosal involvement in two siblings.
Minagawa A; Arakura F; Koga H; Tokuda Y; Koga H; Hashimoto T; Okuyama R
Eur J Dermatol; 2015 Apr; 25(2):186-8. PubMed ID: 25513716
[No Abstract] [Full Text] [Related]
2. Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.
Ono S; Tanioka M; Tanizaki H; Fujisawa A; Koga H; Hashimoto T; Kamiya K; Aoyama Y; Iwatsuki K; Miyachi Y
Br J Dermatol; 2013 Jun; 168(6):1357-60. PubMed ID: 23738642
[No Abstract] [Full Text] [Related]
3. Case of pemphigoid vegetans positive with both BP180 and BP230 in enzyme-linked immunosorbent assays.
Nagamoto E; Fujisawa A; Jinnin M; Koga H; Ishii N; Hashimoto T; Yoshino Y
J Dermatol; 2014 Jul; 41(7):667-8. PubMed ID: 24985550
[No Abstract] [Full Text] [Related]
4. Unusual bullous pemphigoid without infiltration of inflammatory cells in the skin lesions.
Hara H; Makino T; Matsui K; Takegami Y; Koga H; Fukuda S; Ishii N; Hashimoto T; Shimizu T
Eur J Dermatol; 2014; 24(4):488-9. PubMed ID: 25178966
[No Abstract] [Full Text] [Related]
5. Bullous pemphigoid-like eruption subsequent to scabies: bullous scabies or bullous pemphigoid?
Huang MX; Li ZS; Luo DQ; Lin Q
G Ital Dermatol Venereol; 2015 Jun; 150(3):337-9. PubMed ID: 25658439
[No Abstract] [Full Text] [Related]
6. Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid.
Roussel A; Benichou J; Randriamanantany ZA; Gilbert D; Drenovska K; Houivet E; Tron F; Joly P
Arch Dermatol; 2011 Mar; 147(3):293-8. PubMed ID: 21422336
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
[TBL] [Abstract][Full Text] [Related]
8. Analysis of antigens targeted by circulating IgG and IgA antibodies in patients with mucous membrane pemphigoid predominantly affecting the oral cavity.
Carrozzo M; Cozzani E; Broccoletti R; Carbone M; Pentenero M; Arduino P; Parodi A; Gandolfo S
J Periodontol; 2004 Oct; 75(10):1302-8. PubMed ID: 15562906
[TBL] [Abstract][Full Text] [Related]
9. [Auto-immune bullous diseases autoantibodies (pemphigus, bullous pemphigoid): what the dermatologist must know].
Ingen-Housz-Oro S; Hüe S; Grootenboer-Mignot S; André C
Ann Dermatol Venereol; 2013; 140(8-9):563-70. PubMed ID: 24034645
[No Abstract] [Full Text] [Related]
10. BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?
Schmidt T; Sitaru C; Amber K; Hertl M
Br J Dermatol; 2014 Aug; 171(2):212-9. PubMed ID: 24601973
[TBL] [Abstract][Full Text] [Related]
11. ELISA instead of indirect IF in patients with BP: Comment on "Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid".
Chan LS
Arch Dermatol; 2011 Mar; 147(3):291-2. PubMed ID: 21422335
[No Abstract] [Full Text] [Related]
12. IgG and IgA antibodies in linear IgA/IgG bullous dermatosis target the ectodomain of bullous pemphigoid antigen 2.
Hertl M; Büdinger L; Christophoridis S; Yancey KB; Borradori L
Br J Dermatol; 1999 Apr; 140(4):750-2. PubMed ID: 10233336
[No Abstract] [Full Text] [Related]
13. [Bullous pemphigoid: diagnosis and therapy].
Kneisel A; Hertl M
Wien Med Wochenschr; 2014 Sep; 164(17-18):363-71. PubMed ID: 25077677
[TBL] [Abstract][Full Text] [Related]
14. IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses.
Feliciani C; Caldarola G; Kneisel A; Podstawa E; Pfütze M; Pfützner W; Hertl M
Br J Dermatol; 2009 Aug; 161(2):306-12. PubMed ID: 19485996
[TBL] [Abstract][Full Text] [Related]
15. Blistering insights into the pathogenesis of bullous pemphigoid.
Wong HK; Bechtel MA
Clin Immunol; 2012 Feb; 142(2):101-4. PubMed ID: 22217422
[No Abstract] [Full Text] [Related]
16. IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain.
Egan CA; Reddy D; Nie Z; Taylor TB; Schmidt LA; Meyer LJ; Petersen MJ; Hashimoto T; Marinkovich MP; Zone JJ
J Invest Dermatol; 2001 Feb; 116(2):348-50. PubMed ID: 11180014
[No Abstract] [Full Text] [Related]
17. Four Japanese patients with cicatricial pemphigoid showing both IgG and IgA antibodies against the 180 kDa bullous pemphigoid antigen.
Hashimoto T; Han-Yaku H; Higashiyama M; Hashimoto K; Iwatsuki K; Kaneko F; Murakami H; Nishikawa T
Br J Dermatol; 1997 Aug; 137(2):305-6. PubMed ID: 9292089
[No Abstract] [Full Text] [Related]
18. Clinical and immunological factors associated with bullous pemphigoid relapse.
Fine JD
JAMA Dermatol; 2014 Jan; 150(1):34. PubMed ID: 24226151
[No Abstract] [Full Text] [Related]
19. Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.
Zakka LR; Keskin DB; Reche P; Ahmed AR
Clin Exp Immunol; 2010 Nov; 162(2):224-36. PubMed ID: 21069937
[TBL] [Abstract][Full Text] [Related]
20. [Bullous pemphigoid].
Ohyama M; Amagai M
Ryoikibetsu Shokogun Shirizu; 2000; (31):274-6. PubMed ID: 11269078
[No Abstract] [Full Text] [Related]
[Next] [New Search]